Sign In
Buy DMTK
$0.0940
+0 (+0%)
At Close: Oct 21, 2024
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
02:22pm, Saturday, 16'th Jan 2021
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying c
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that SKIN has pub
DermTech Announces Appointment of General Counsel
04:30pm, Tuesday, 05'th Jan 2021
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the appointment o
Here's Why You Should Really Own DermTech Stock in 2021
02:27pm, Tuesday, 05'th Jan 2021
The biotech's skin cancer diagnostic tool is a significant improvement over the standard of care.
Why DermTech Stock Is Soaring Today
11:13am, Wednesday, 30'th Dec 2020
The company's genomic test for melanoma won another positive coverage decision.
DermTech Receives Positive Medical Coverage by Geisinger Health System
05:05pm, Tuesday, 29'th Dec 2020
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that Geisinger He
DermTech Management to Present at the ICR Conference 2021
04:01pm, Monday, 28'th Dec 2020
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ:DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that DermTech mana
DermTech (DMTK) in Focus: Stock Moves 6% Higher
09:02am, Monday, 28'th Dec 2020
DermTech (DMTK) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
DermTech: Stickers To Diagnose Cancer
10:29pm, Monday, 21'st Dec 2020
DermTech: Stickers To Diagnose Cancer
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the topline resul
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its inclusion in
DermTech Enters Into Agreement With Blue Shield of California
04:01pm, Thursday, 10'th Dec 2020
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it has entered in
DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit
04:30pm, Thursday, 03'rd Dec 2020
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the presentation
DermTech Enters Agreement with Blue Cross Blue Shield of Illinois
08:00am, Friday, 20'th Nov 2020
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it has entered in
